LY-4052031
N/A
Report date: 2026/03/26 20:00:17
Base Information
Drug NameLY-4052031
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications +[13]
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory +[8]
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesEli Lilly & Company Lilly France
China Registration ClassN/A
Develop Information
Active CompaniesEli Lilly And CompanyLilly Suzhou Pharmaceutical Co Ltd
Inactive CompaniesEli Lilly & Company Lilly France
Active Indications +[12]
Inactive Indications
Other Information
ATC CodeN/A
Related LinksN/A